In this presentation from the 2016 “European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes”, Dr. Srdan Verstovsek provides an update on several JAK inhibitors in development for use in the treatment of myelofibrosis (MF).
A continuing education program related to this video is offered at the following location:
http://elc.imedex.com/ELC/Activity-Search.aspx?search=7210
© 2016 Imedex, LLC.
Advertisement